c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma—an immunocytochemical study
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (1) , 16-22
- https://doi.org/10.1016/s0959-8049(05)80010-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Expression of the C‐erbB‐3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1The Journal of Pathology, 1993
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992
- Expression of the ERBB3 gene product in breast cancerBritish Journal of Cancer, 1992
- Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancerBritish Journal of Cancer, 1992
- The HER-2/neu oncogene in breast cancer: so what is new?Journal of Clinical Oncology, 1992
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroupBritish Journal of Cancer, 1991
- 4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancerInternational Journal of Cancer, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987